SCHEMBL1722558

SCHEMBL1722558

O=C(O)NCCC(=O)c1cccc([S+]([O-])CC2CCCCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 1/20 0.38
HDAC6 Q9UBN7 1/20 0.37
KCNH2 Q12809 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
LDLR P01130 2/20 0.35
EPHX2 P34913 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3388399 0.84 KMT2A (0.40) SMN1; SMN2KMT2AMEN1POLBHDAC6
SCHEMBL1725661 0.84 EPHX1 (0.40) SMN1; SMN2KMT2AMEN1POLBHDAC6
SCHEMBL1710677 0.83 KMT2A (0.38) SMN1; SMN2KMT2AMEN1POLBHDAC6
SCHEMBL3390536 0.83 EPHX1 (0.38) SMN1; SMN2KMT2AMEN1LDLRALDH1A1
SCHEMBL1725422 0.79 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MAPTGAAHPGD
SCHEMBL1710545 0.78 BCHE (0.35) KMT2AMEN1EPHX2
SCHEMBL1726498 0.76 KMT2A (0.35) SMN1; SMN2KMT2AMEN1HDAC6KCNH2
SCHEMBL1710420 0.76 HAO1 (0.37) KMT2AMEN1POLBRAB9ANPC1
SCHEMBL2150642 0.75 SMN1; SMN2 (0.48) SMN1; SMN2KMT2AMEN1POLBHDAC6
SCHEMBL2150853 0.74 MEN1 (0.46) SMN1; SMN2KMT2AMEN1HDAC6RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344451-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2011-07-20 EP disclosed
WO-2010028088-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-03-11 WO disclosed